Leonardo Drs (DRS) revenue and earnings history
Leonardo Drs reported revenue of $3.65B for fiscal 2025 (year ended Dec 31, 2025), +12.8% on the year before, and net income of $278M.
Over 6 years, from fiscal 2019 to fiscal 2025, revenue grew at a compound rate of +5.1% a year.
Revenue and net income, 7 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $3.65B+12.8% | $348M | $278M | $366M | $139M | $227M | $32M | $35M | — | $647M | $348M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Leonardo Drs (DRS) on OQRO.
Common questions
What was Leonardo Drs's revenue in fiscal 2025?
$3.65B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 27, 2026. That is +12.8% on fiscal 2024 ($3.23B).
How fast has Leonardo Drs's revenue grown?
From $2.71B in fiscal 2019 to $3.65B in fiscal 2025: a compound annual growth rate of +5.1% over 6 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Leonardo Drs tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
